AMAL vs INCY · P/E 9.8, rev $226.5M vs P/E 14, rev $5.14B
Amalgamated Bank (AMAL) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Amalgamated Bank (AMAL) is a banks - regional company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported AMAL revenue for 2026-06-30 was $226.5M. Net income was $60.0M. AMAL currently screens at market cap $1.02B and trailing P/E 9.8.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
AMAL currently screens at market cap $1.02B and trailing P/E 9.8. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the AMAL and INCY stock pages for the full models.
Not investment advice.